Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Opyl Ltd. ( (AU:PKY) ) has issued an announcement.
PathKey.AI Ltd announced the resignation of Mr. Saurabh Jain as Executive Chairman and Director due to his other growing commitments. Mr. Jain played a crucial role in the company’s transformation and commercialization of its AI platform, TrialKey. He will remain involved as a shareholder and advocate. Mr. Damon Rasheed, the company’s Chief Technology Officer and founder of TrialKey, has been appointed as the new Executive Chairman, ensuring continuity in leadership and strategy. Additionally, Mr. Paul Niardone has been appointed as a Non-Executive Director, bringing extensive experience in equity capital markets and strategic expansion.
More about Opyl Ltd.
PathKey.AI Ltd is a leader in AI-driven clinical trial optimization, focusing on the global life sciences and biotechnology sectors. The company’s flagship AI platform, TrialKey, is at the forefront of its operations, enhancing the efficiency and effectiveness of clinical trials.
Average Trading Volume: 746,935
Technical Sentiment Signal: Sell
Current Market Cap: A$7.57M
See more insights into PKY stock on TipRanks’ Stock Analysis page.